Pages that link to "Q69934914"

The following pages link to Distribution and activity of antineoplastic drugs in a tumor model (Q69934914):

Displaying 31 items.

• Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity (Q24652600) (← links)
• Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids (Q31542532) (← links)
• In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles (Q33922364) (← links)
• Retreatment of patients with the same chemotherapy: implications for clinical mechanisms of drug resistance (Q34181271) (← links)
• Determinants of drug delivery and transport to solid tumors (Q34328553) (← links)
• Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids (Q34649999) (← links)
• Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. (Q35202899) (← links)
• Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors (Q35845149) (← links)
• Repopulation of cancer cells during therapy: an important cause of treatment failure (Q36167592) (← links)
• Multicellular membranes as an in vitro model for extravascular diffusion in tumours. (Q36291864) (← links)
• Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. (Q36615053) (← links)
• P53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer. (Q37012038) (← links)
• Ovarian cancer spheroid shrinkage following continuous exposure to cisplatin is a function of spheroid diameter (Q38703668) (← links)
• E-cadherin increasing multidrug resistance protein 1 via hypoxia-inducible factor-1α contributes to multicellular resistance in colorectal cancer (Q38848488) (← links)
• In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog (Q38990370) (← links)
• The distribution and retention of paclitaxel and doxorubicin in multicellular layer cultures (Q39408049) (← links)
• Drug and radiation resistance in spheroids: cell contact and kinetics (Q40630918) (← links)
• Contributions of flow cytometry to studies with multicell spheroids. (Q41503629) (← links)
• Diversity of penetration of anti-cancer agents into solid tumours (Q41676851) (← links)
• Cisplatin and CCNU synergism in spheroid cell subpopulations (Q41711752) (← links)
• Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage? (Q41749306) (← links)
• Expression of verapamil hypersensitivity in multidrug-resistant cells grown as multicellular spheroids (Q41749371) (← links)
• Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration (Q41945817) (← links)
• Time- and concentration-dependent penetration of doxorubicin in prostate tumors (Q41997550) (← links)
• Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours. (Q42859352) (← links)
• Collaborative clinical trials: quality or quantity? (Q52927934) (← links)
• Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30. (Q53971414) (← links)
• In vitro evaluation of Taxol combined with radiations in human squamous cell carcinoma spheroids (Q73040866) (← links)
• Conventional cancer therapy: promise broken or promise delayed? (Q74599516) (← links)
• Clinical aspects of drug delivery to tumors (Q77436547) (← links)
• Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000 (Q92312014) (← links)